2	O
.	O

CLINICAL	O
PROTEOMICS	O
AT	O
THE	O
BEDSIDE	O

Clinically	O
-	O
based	O
proteomics	O
has	O
a	O
large	O
potential	O
for	O
the	O
development	O
of	O
strategies	O
which	O
aim	O
to	O
alleviate	O
risk	O
associated	O
with	O
cardiac	B-Organ
disease	O
.	O

Biomarkers	O
that	O
are	O
used	O
in	O
clinical	O
practice	O
are	O
highly	O
useful	O
in	O
that	O
they	O
support	O
medical	O
decision	O
making	O
,	O
by	O
complementing	O
other	O
diagnostic	O
tests	O
,	O
such	O
as	O
the	O
medical	O
history	O
,	O
physical	O
examination	O
,	O
and	O
various	O
other	O
special	O
tests	O
.	O

Theoretically	O
,	O
there	O
are	O
three	O
criteria	O
that	O
,	O
if	O
satisfied	O
,	O
would	O
provide	O
an	O
optimal	O
biomarker	O
of	O
the	O
disease	O
state	O
.	O

First	O
,	O
the	O
potential	O
biomarkers	O
must	O
be	O
easily	O
measurable	O
in	O
a	O
short	O
time	O
period	O
at	O
a	O
cost	O
that	O
is	O
practical	O
.	O

Second	O
,	O
elevation	O
of	O
this	O
protein	O
would	O
offer	O
diagnostic	O
information	O
that	O
was	O
not	O
previously	O
present	O
in	O
the	O
absence	O
of	O
the	O
protein	O
.	O

Third	O
,	O
the	O
information	O
obtained	O
would	O
aid	O
in	O
the	O
medical	O
decision	O
making	O
process	O
performed	O
by	O
the	O
clinician	O
[	O
11	O
]	O
.	O

Fulfillment	O
of	O
such	O
criteria	O
encourages	O
follow	O
-	O
up	O
of	O
such	O
a	O
biomarker	O
in	O
other	O
model	O
systems	O
or	O
patient	O
cohort	O
samples	O
.	O

For	O
instance	O
,	O
cardiac	O
troponin	O
I	O
has	O
been	O
previously	O
shown	O
to	O
fulfill	O
such	O
criteria	O
,	O
and	O
further	O
follow	O
-	O
up	O
in	O
patient	O
cohorts	O
is	O
underway	O
.	O

Recently	O
,	O
this	O
approach	O
was	O
utilized	O
to	O
ascertain	O
whether	O
Cardiac	O
Troponin	O
I	O
(	O
CTN	O
I	O
)	O
or	O
Creatine	O
Kinase	O
-	O
Myoglobin	O
(	O
CK	O
-	O
MB	O
)	O
could	O
be	O
used	O
as	O
short	O
-	O
term	O
or	O
long	O
-	O
term	O
markers	O
of	O
risk	O
associated	O
with	O
cardiac	B-Organ
surgery	O
[	O
12	O
]	O
.	O

In	O
this	O
study	O
,	O
a	O
patient	O
cohort	O
of	O
252	O
individuals	O
who	O
had	O
undergone	O
cardiac	B-Organ
surgery	O
was	O
used	O
to	O
analyze	O
levels	O
of	O
these	O
two	O
proteins	O
in	O
blood	B-Organism_substance
.	O

Not	O
only	O
was	O
CTN	O
-	O
I	O
shown	O
to	O
be	O
a	O
strong	O
predictor	O
of	O
mortality	O
,	O
but	O
increases	O
in	O
the	O
levels	O
of	O
this	O
protein	O
also	O
correlated	O
well	O
with	O
increases	O
in	O
mortality	O
.	O

Findings	O
from	O
this	O
study	O
support	O
the	O
utilization	O
of	O
patient	O
cohorts	O
as	O
a	O
means	O
to	O
ease	O
the	O
transition	O
from	O
bench	O
to	O
bedside	O
.	O

